Our B cell engineering service specifically transfers your gene of interest into the CCR5 GSH site in human chromosome 3 via CRISPR/Cas9-mediated homologous recombination or other genomic editing technologies. Our engineered B cells have wide applications in therapeutics, industry, and basic research.